Summary
Machine-generated summaryZakłady Farmaceutyczne Polpharma SA sought research services under Request for Proposals No. INC/18/ PR153728/2026-90231-289587 (notice number 2026-90231-289587). The procurement related to the project FENG.01.01-IP.01-0007/25, concerning the development of an innovative technological and analytical platform for the production of medicines containing oligonucleotides in a ready-to-use form. The classified CPV code was 73100000-3, covering research and experimental development services. The procedure was a single part. The deadline for submitting bids was 28 September 2026, and the call is now closed for bids.
Key points
- Reference
- 2026-90231-289587
Original text
Official source
Source: Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej)
Always verify details on the official notice.
Report an error in this notice
Last verified against Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) 2 weeks ago
The buyer
Full buyer profileZakłady Farmaceutyczne Polpharma SA
- notices in the register
- 3
2 open tenders right now
- Inquiry LERCAN/6/PR 138141/2026-90231-293537 for a bioequivalence study comparing the Test Product and the Reference Product in healthy volunteers 19 days left
- Opracowanie i rozwój innowacyjnego rozwiązania - złożonego, dwuskładnikowego produktu leczniczego, ukierunkowanego na terapię nadciśnienia tętniczego” w ramach programu Fundusze Europejskie dla Nowoczesnej Gospodarki 2021-2027, działanie „Ścieżka SMART”, w ramach 1 Priorytetu „Wsparcie dla przedsiębiorców”. Development and development of an innovative solution - a complex, two-component medicinal product aimed at the therapy of hypertension" under the European Funds for Modern Economy 2021-2027 34 days left
Market context
- open now in Research & development
- 440
- median open notice
- €295,000
Who wins in this market
Many suppliersPoland · Research & development
- different companies won awards here
- 220
- of the awards went to the three most frequent winners
- 6%
- buyers awarded contracts here
- 134
Based on 284 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 2.3
- of those lots received a single tender
- 33%
- of the awards went to companies based in another country
- 6%
- of the tenders came from another country
- 6%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Read before bidding
- Submission deadline
-
Was:
September 27, 2026, 21:59 - Now: September 28, 2026, 21:59 1 day later
- Scope and criteria
- The description was reworded. Re-read it before you bid.
Follow this tender and we email you the moment it changes. Create account
Similar tenders
Open now
Awarded before
Never miss a tender like this
49 new notices in Research & development in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Research and experimental development services: an email when new tenders arrive under it, no account needed.